Psychedelics as transformative therapeutics

BL Roth, RH Gumpper - American Journal of Psychiatry, 2023 - Am Psychiatric Assoc
Over the past decade, psychedelic compounds have emerged as potentially transformative
therapeutics for a variety of intractable neuropsychiatric conditions. However, historically …

The implication of 5-HT receptor family members in aggression, depression and suicide: similarity and difference

NK Popova, AS Tsybko, VS Naumenko - International journal of molecular …, 2022 - mdpi.com
Being different multifactorial forms of psychopathology, aggression, depression and suicidal
behavior, which is considered to be violent aggression directed against the self, have …

Evidence for Possible Involvement of 5-HT2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications

RB Rothman, MH Baumann, JE Savage, L Rauser… - Circulation, 2000 - Am Heart Assoc
Background—Serotonergic medications with various mechanisms of action are used to treat
psychiatric disorders and are being investigated as treatments for drug dependence. The …

Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application

MJ Millan - Pharmacology & therapeutics, 2006 - Elsevier
Major depression is a debilitating and recurrent disorder with a substantial lifetime risk and a
high social cost. Depressed patients generally display co-morbid symptoms, and depression …

The multiplicity of serotonin receptors: uselessly diverse molecules or an embarrassment of riches?

BL Roth, E Lopez, S Patel, WK Kroeze - The Neuroscientist, 2000 - journals.sagepub.com
A large number of 5-HT receptors (> 15) have been identified by molecular cloning
technology over the past 10 years. This review briefly summarizes available information …

Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding

C Sánchez, J Hyttel - Cellular and molecular neurobiology, 1999 - Springer
The present survey compares the effects of antidepressants and their principal metabolites
on reuptake of biogenic amines and on receptor binding. The following antidepressants …

Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex

FP Bymaster, W Zhang, PA Carter, J Shaw… - …, 2002 - Springer
Rationale: The selective serotonin uptake inhibitor (SSRI) fluoxetine has been shown to not
only increase the extracellular concentrations of serotonin, but also dopamine and …

Fluoxetine: a case history of its discovery and preclinical development

L Perez-Caballero, S Torres-Sanchez… - Expert opinion on …, 2014 - Taylor & Francis
Introduction: Depression is a multifactorial mood disorder with a high prevalence worldwide.
Until now, treatments for depression have focused on the inhibition of monoaminergic …

Predicting drug–target interactions using probabilistic matrix factorization

MC Cobanoglu, C Liu, F Hu, ZN Oltvai… - Journal of chemical …, 2013 - ACS Publications
Quantitative analysis of known drug–target interactions emerged in recent years as a useful
approach for drug repurposing and assessing side effects. In the present study, we present a …

Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies

MJ Millan - Therapies, 2005 - Elsevier
Abstract Serotonin (5-HT) 2C receptors play an important role in the modulation of
monoaminergic transmission, mood, motor behaviour, appetite and endocrine secretion …